3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
4
Breast Neoplasms
3
Pancreatic Neoplasms
2
Glioblastoma
2
Smoking Cessation
1
Quality of Life
1
Patient Compliance
1
Overweight
1
Obesity
1
Motor Activity
1
Melanoma
1
Lung Neoplasms
1
Inflammation
1
Glioma
1
GastroEsophageal Cancer
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Advanced Malignant Solid Neoplasm
1
Interventions
ruxolitinib
9
fludarabine phosphate
8
fludarabine
8
Whole-Body Irradiation
8
Specimen Handling
7
Cytarabine
7
Cyclophosphamide
7
Mycophenolic Acid
6
Tacrolimus
5
Injections
5
Busulfan
5
Biopsy
5
Azacitidine
5
Stem Cell Transplantation
4
Sirolimus
4
Peripheral Blood Stem Cell Transplantation
4
Melphalan
4
Granulocyte Colony-Stimulating Factor
4
CPX-351
4
venetoclax
3
luspatercept
3
decitabine and cedazuridine drug combination
3
Liposomes
3
Idarubicin
3
Daunorubicin
3
Cyclosporine
3
Blood Specimen Collection
3
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
3
selinexor
2
nilotinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Diet Therapy
×
90 days
×
Clear all
No trials found.